Top

BY MD Anderson staff

When asked why she’s so passionate about preventing the spread of HPV, Lois Ramondetta, M.D., is quick to answer.

“Cancers are horrible, no matter what type or how a person gets them. But nothing is more upsetting than seeing a cancer that’s completely preventable.”

Unfortunately, stopping the most common sexually transmitted infection — one that almost all sexually active men and women will get at some time in their lives...

BY Ronda Wendler

Since its introduction in the 1940s, the Pap test has been successfully detecting abnormal cells in the cervix that, if left untreated, could...

BY Ernest Hawk, M.D.

In April, new federal data was released showing e-cigarette use has tripled among students in middle and high school. We asked MD Anderson...

BY Ron Gilmore

New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, have shown therapeutic promise for several cancers, including the most common form of lung cancer.

The PD-L1-based therapies inhibit the protein, but they don’t work for everyone. Now, MD Anderson scientists have uncovered more detail about how PD-L1 is regulated by the tumor suppressor gene p53, allowing non-small cell lung cancer...

BY Ron Gilmore

Mutations of the KRAS gene are commonly known to lead to cancer. But deeper understanding of exactly how they do this continues to be explored...

BY Ron Gilmore

For some time, cancer scientists have considered alpha-amanitin, the toxin derived from “death cap” mushrooms, as a possible cancer treatment...

BY Ron Gilmore

Successful ovarian cancer treatment often relies on catching it early. A study at MD Anderson may help point to a new method of detecting...

BY Ron Gilmore

Cancer scientist James Allison, Ph.D., internationally known for his role in developing a new class of cancer immunotherapies, has been named...